We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+14.91%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$141B
AUM Growth
+$12.9B
Cap. Flow
-$2.58B
Cap. Flow %
-1.83%
Top 10 Hldgs %
23.5%
Holding
2,555
New
125
Increased
501
Reduced
893
Closed
65

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$46.9M
2
NET icon
Cloudflare
NET
+$38.2M
3
TXG icon
10x Genomics
TXG
+$33.7M
4
TDOC icon
Teladoc Health
TDOC
+$31.9M
5
PDD icon
Pinduoduo
PDD
+$31.4M

Sector Composition

Rank Sector Weight
1 Technology 26.63%
2 Healthcare 14.53%
3 Consumer Discretionary 13.88%
4 Communication Services 10.7%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNDX icon
2026
Syndax Pharmaceuticals
SNDX
$1.71B
$1.63M ﹤0.01%
+73,200
New +$1.52M
VNDA icon
2027
Vanda Pharmaceuticals
VNDA
$306M
$1.62M ﹤0.01%
123,600
ENTA icon
2028
Enanta Pharmaceuticals
ENTA
$383M
$1.62M ﹤0.01%
38,500
HLIT icon
2029
Harmonic Inc
HLIT
$1.5B
$1.62M ﹤0.01%
218,915
ECHO
2030
DELISTED
Echo Global Logistics, Inc.
ECHO
$1.61M ﹤0.01%
60,200
-700
-1% -$19.7K
PI icon
2031
Impinj
PI
$5.34B
$1.61M ﹤0.01%
38,500
VNOM icon
2032
Viper Energy
VNOM
$15.2B
$1.61M ﹤0.01%
138,400
PDFS icon
2033
PDF Solutions
PDFS
$2.14B
$1.6M ﹤0.01%
74,300
+7,400
+11% +$155K
KEN icon
2034
Kenon Holdings
KEN
$3.51B
$1.6M ﹤0.01%
54,625
TARO
2035
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$1.6M ﹤0.01%
+21,800
New +$1.4M
EBSB
2036
DELISTED
Meridian Bancorp, Inc.
EBSB
$1.6M ﹤0.01%
107,200
ADTN icon
2037
Adtran
ADTN
$676M
$1.6M ﹤0.01%
108,100
OSG
2038
Octave Specialty Group
OSG
$214M
$1.6M ﹤0.01%
103,800
TBBK icon
2039
The Bancorp
TBBK
$2.84B
$1.6M ﹤0.01%
116,900
VET icon
2040
Vermilion Energy
VET
$1.74B
$1.59M ﹤0.01%
356,267
ERF
2041
DELISTED
Enerplus Corporation
ERF
$1.59M ﹤0.01%
507,255
KELYA icon
2042
Kelly Services Class A
KELYA
$555M
$1.59M ﹤0.01%
77,100
LBRT icon
2043
Liberty Energy
LBRT
$3.55B
$1.58M ﹤0.01%
153,500
+4,300
+3% +$39.2K
PGEN icon
2044
Precigen
PGEN
$2.27B
$1.58M ﹤0.01%
155,000
ARR
2045
Armour Residential REIT
ARR
$2.39B
$1.58M ﹤0.01%
29,282
RPT
2046
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$1.58M ﹤0.01%
182,600
JBSS icon
2047
John B. Sanfilippo & Son
JBSS
$1.01B
$1.57M ﹤0.01%
19,976
-300
-1% -$22.8K
LMAT icon
2048
LeMaitre Vascular
LMAT
$1.88B
$1.57M ﹤0.01%
38,900
AMRS
2049
DELISTED
Amyris Inc.
AMRS
$1.57M ﹤0.01%
255,100
CBB
2050
DELISTED
Cincinnati Bell Inc.
CBB
$1.57M ﹤0.01%
103,100

Similar funds

Swiss National Bank's Q4 2020 Portfolio in Review

As of Q4 2020, Swiss National Bank held 2,555 positions worth $141B, up 10% from $128B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Swiss National Bank's Q4 2020 filing shows 125 new, 501 increased, 893 reduced and 65 closed positions. Its largest new stake was Cloudflare: 582,300 shares worth $44.2M. The largest sale was Apple, an estimated $349M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q4 2020 buy was Cloudflare: 582,300 shares worth $44.2M.
  • Swiss National Bank added most to Viatris in Q4 2020, an estimated $46.9M increase.
  • Swiss National Bank's biggest Q4 2020 reduction was Apple, cutting an estimated $349M.
  • Swiss National Bank fully exited Immunomedics Inc in Q4 2020, selling an estimated $37.8M.
  • Swiss National Bank's ten largest holdings make up 24% of its $141B portfolio in Q4 2020.
  • Swiss National Bank opened 125 new positions and closed 65 in Q4 2020.
  • Swiss National Bank's portfolio value rose 10% quarter-over-quarter to $141B.

Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.